乐鱼app官网登录入口

Congratulations on the launch of 9 new Huake products!

Published: 2018-12-10| Size:L M S|

Heart Type Fatty Acid Binding Protein(H-FABP)

Registration Certificate No:京械注20182400401Clinical Significance: compared with other biochemical diagnostic indexes (such as myo, CK-MB) in the early diagnosis of AMI, it has comprehensive advantages in timeliness, sensitivity and specificity, and is a new and better index for the early diagnosis of AMI


Myeloperoxidase(MPO)

Registration Certificate No:京械注20182400398Clinical Significance: It can reflect the inflammatory degree of intima, that is, the severity and dynamic change of atherosclerosis, and has excellent performance in the early prediction of coronary heart disease


Serum Amyloid A(SAA)

Registration Certificate No:京械注20182400397Clinical Significance: It is an acute phase protein with high specificity and sensitivity in the diagnosis of virus infection


Neutrophil Gelatinase Related Lipid Transporter(NGAL)

Registration Certificate No:京械注20182400399Clinical Significance: Early diagnosis of acute renal injury and specific index of risk stage of renal injury


Cystatin C(Cys-C)

Registration Certificate No:京械注20182400400Clinical Significance: It is an ideal endogenous marker reflecting the change of glomerular filtration rate


Retinol Binding Protein(RBP)

Registration Certificate No:京械注20182400396Clinical Significance: A sensitive index for the diagnosis of early or slight renal damage. Especially the renal damage caused by hypertension and diabetes is more obvious


Microalbuminuria(MAU)

Registration Certificate No:京械注20182400395Clinical Significance: As an early diagnostic index of renal functional injury


Pepsinogen Ⅰ(PG)

Registration Certificate No:京械注20182400403Clinical Significance: It is a primary screening index and a monitoring index for the treatment of superficial erosive atrophic gastritis, gastric ulcer, duodenal ulcer, gastric cancer and other gastric diseases


Pepsinogen Ⅱ(PGⅡ)

Registration Certificate No:京械注20182400402Clinical Significance: It is a primary screening index and a monitoring index for the treatment of superficial erosive atrophic gastritis, gastric ulcer, duodenal ulcer, gastric cancer and other gastric diseases